Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority study
Mills, Anthony, MD, Arribas, Jose R, MD, Andrade-Villanueva, Jaime, Prof, DiPerri, Giovanni, MD, Van Lunzen, Jan, Prof, Koenig, Ellen, MD, Elion, Richard, MD, Cavassini, Matthias, MD, Madruga, Jose Valdez, MD, Brunetta, Jason, MD, Shamblaw, David, MD, DeJesus, Edwin, MD, Orkin, Chloe, MBBch, Wohl, David A, MD, Brar, Indira, MD, Stephens, Jeffrey L, MD, Girard, Pierre-Marie, Prof, Huhn, Gregory, MD, Plummer, Andrew, BS, Liu, Ya-Pei, PhD, Cheng, Andrew K, MD, McCallister, Scott, Dr
Published in The Lancet infectious diseases (01.01.2016)
Published in The Lancet infectious diseases (01.01.2016)
Get full text
Journal Article